Chanda Sanjay
Insider CIK 1571820 · ANAC VP, Int. Head of Drug Dev. · ANTX Chief Development Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 66,000 | — | $0 | 66,000 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 41,665 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 41,665 | — | $0 | 41,665 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 57,950 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 57,950 | — | $0 | 57,950 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 66,000 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-02-20 | 2026-02-23 | 77,000 | — | $0 | 77,000 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2026-02-20 | 2026-02-23 | 38,000 | — | $0 | 118,823 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2026-01-06 | 2026-01-07 | 5,956 | $1.01 | $6.0K | 75,823 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2026-01-05 | 2026-01-07 | 3,295 | $1.00 | $3.3K | 81,779 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2025-02-26 | 2025-02-28 | 100,500 | — | $0 | 100,500 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2025-02-26 | 2025-02-28 | 50,250 | — | $0 | 80,074 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2025-01-03 | 2025-01-07 | 2,957 | $1.34 | $4.0K | 29,824 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2024-03-15 | 2024-03-18 | 55,000 | — | $0 | 55,000 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2024-03-15 | 2024-03-18 | 27,500 | — | $0 | 28,235 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2024-03-15 | 2024-03-29 | 27,500 | — | $0 | 28,235 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2023-02-15 | 2023-02-17 | 57,950 | — | $0 | 57,950 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2022-05-12 | 2022-05-16 | 66,000 | — | $0 | 66,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2015-03-04 | 2015-03-04 | 48 | $7.55 | $362 | 13,552 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2015-03-04 | 2015-03-04 | 4,952 | $7.25 | $35.9K | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2015-03-04 | 2015-03-04 | 48 | $7.55 | $362 | 29,135 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-03-04 | 2015-03-04 | 4,952 | $45.00 | $222.8K | 29,087 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2015-03-04 | 2015-03-04 | 4,952 | $7.25 | $35.9K | 34,039 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-03-04 | 2015-03-04 | 48 | $45.00 | $2.2K | 29,087 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2015-02-03 | 2015-02-05 | 20,845 | — | $0 | 20,845 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2015-02-03 | 2015-02-05 | 1,475 | — | $0 | 1,475 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award | 2015-02-03 | 2015-02-05 | 5,020 | — | $0 | 29,087 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2014-12-19 | 2014-12-22 | 7,011 | $6.92 | $48.5K | 18,489 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2014-12-19 | 2014-12-22 | 12,062 | $5.59 | $67.4K | 14,938 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2014-12-19 | 2014-12-22 | 12,062 | $5.59 | $67.4K | 23,068 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2014-12-19 | 2014-12-22 | 7,011 | $6.92 | $48.5K | 11,006 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2014-11-26 | 2014-12-01 | 5,000 | $7.25 | $36.3K | 4,952 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-11-26 | 2014-12-01 | 5,000 | $35.00 | $175.0K | 3,995 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2014-11-26 | 2014-12-01 | 5,000 | $7.25 | $36.3K | 8,995 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2014-09-10 | 2014-09-12 | 4,953 | $5.00 | $24.8K | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2014-09-10 | 2014-09-12 | 5,047 | $7.25 | $36.6K | 9,952 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2014-09-10 | 2014-09-12 | 4,953 | $5.00 | $24.8K | 8,948 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-09-10 | 2014-09-12 | 5,047 | $24.25 | $122.4K | 3,995 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-09-10 | 2014-09-12 | 4,953 | $24.25 | $120.1K | 3,995 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2014-09-10 | 2014-09-12 | 5,047 | $7.25 | $36.6K | 9,042 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2014-02-07 | 2014-02-10 | 47,000 | — | $0 | 47,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2013-11-07 | 2013-11-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2013-04-12 | 2013-04-16 | 60,000 | — | $0 | 60,000 | SEC↗ |